The present invention relates to the field ophthalmic compositions. In particular, the present invention provides a method of producing an aqueous ophthalmic composition which includes micronized particles of a carbonic anhydrase inhibitor insoluble or hardly soluble in water and is intended to address the issues of blurred vision from administration of compositions to the eye